#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Subarachnoid haemorrhage Epilepsy with myoclonic-atonic seizures Severe myoclonic epilepsy of infancy Hereditary motor and sensory neuropathy Vulval cancer Prophylaxis against transplant rejection Stress cardiomyopathy Behcet's syndrome Hyperphagia Ehlers-Danlos syndrome Neutropenia Uterine leiomyosarcoma Hormone-dependent prostate cancer Oropharyngeal cancer recurrent Thrombocytosis More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Life with Disease Idiopathic inflammatory myopathy – Trials in Disease Phenylketonuria – Life with Disease Haemophilia – Diagnostics Noonan syndrome – Treatment Myelodysplastic syndrome with excess blasts – Life with Disease Adrenocortical carcinoma – Trials in Disease Kearns-Sayre syndrome – Treatment Hereditary angioedema – Life with Disease Angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Denosumab Dronedarone Acenocoumarol Radotinib Dihydrochloride Calcium Pantothenate Bp Fluorodopa (18F) Poractant Alfa Enfuvirtide Betaine Citrate Pf-06835375 Indacaterol Eribulin Anhydrous Cyclophosphamide Oxcarbazepine 1,3-BUTYLENE GLYCOL Tecaginlimab Cipepofol Rbl035.2 Nivolumab Zoledronic Acid Monohydrate More therapies…

    Learn about Your Condition

    Skin candida Respiratory tract infection Medulloblastoma Rabies Spermatocele Retinal vein occlusion Microscopic polyangiitis Mental disorder Frontotemporal dementia Nodular melanoma Coronary artery disease Eye inflammation Primary hypercholesterolaemia Laryngeal cancer Neuropathic arthropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Departemental Vendee

Centre Hospitalier Departemental Vendee

Boulevard Stephane Moreau, La Roche sur Yon, 85925, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Lacutamab
    • Gemcitabine
    • Oxaliplatin
    Belgium France Germany Spain

  • Study on the Safety and Immune Response of Meningococcal B Vaccines in Adults with Asplenia: Bexsero, Trumenba, and a Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asplenia
    Investigated Drugs:
    • Neisseria Meningitidis Group B Fhbp Protein Subfamily A
    • Neisseria Meningitidis Group B Fhbp Protein Subfamily B
    • Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
    France

  • Study on Capsaicin for Treating Post-Surgical Neuropathic Pain in Patients

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Capsaicin
    France The Netherlands Poland Spain

  • Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Etrasimod Arginine
    Austria Belgium Bulgaria Croatia Czechia Denmark +9

  • Study on the Effects of Methylprednisolone and Placebo on Ventilator Support Duration in Severe COPD Patients in Intensive Care

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Sodium Chloride
    France

  • Study on Gentamicin and Azithromycin for Treating Lymph Node Infection in Cat Scratch Disease Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bartonellosis
    Investigated Drugs:
    • Gentamicin
    • Azithromycin
    • Sodium Chloride
    France

  • Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Eplontersen
    Austria Belgium Czechia Denmark France Germany +6

  • Study on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Doxorubicin
    • Cyclophosphamide
    • Docetaxel
    Belgium France

  • Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate Ph. Eur.
    • Dexamethasone Sodium Phosphate
    • Bortezomib
    Czechia Denmark France Germany Greece Italy +5

  • Study of Encorafenib and Binimetinib for Patients with BRAFV600E-Mutant Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Binimetinib
    • Encorafenib
    France
Previous Page
1 … 12 13 14 15 16 … 21
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!